Cyramza 500mg Injection: Advanced Treatment for Cancer Patients

Description:

• Cyramza 500mg Injection is an anticancer medication containing the active ingredient Ramucirumab.
• It is a monoclonal antibody drug.

Uses:

• Advanced gastric cancer
• Gastroesophageal junction adenocarcinoma
• Non-small cell lung cancer
• Hepatocellular carcinoma
• Colorectal cancer

Mechanism of Action:

• Cyramza works by targeting and inhibiting the action of a protein called vascular endothelial growth factor receptor 2 (VEGFR2).
• By blocking VEGFR2, this medication prevents cancer cell growth and spread.

Administration:

• Cyramza 500mg Injection is administered by a healthcare professional through intravenous injection in a hospital or clinic setting.
• It is not intended for self-administration.
• The recommended dosage and frequency depend on the type and stage of the cancer being treated, the individual patient's medical history, and overall health status.

Storage:

• Store according to the manufacturer's instructions and in compliance with local regulations.
• Store in a refrigerator at a temperature between 2°C and 8°C (36°F and 46°F).
• Do not freeze or shake the drug.
• Keep in its original packaging until ready to use.
• After reconstitution, use immediately or within 4 hours if stored at room temperature or within 24 hours if stored in a refrigerator.

Safety Advice:

• Pregnancy: Cyramza 500mg Injection is unsafe for pregnant women as it may cause fetal harm.
• Breastfeeding: It is unknown if Cyramza 500mg Injection is excreted in human milk. So breastfeeding women should consult a doctor before starting with this medication.
• Lungs: Consult your doctor if you have any lung diseases before starting the treatment.
• Liver: Regular monitoring of liver function tests is recommended.
• Alcohol: It is generally recommended that patients taking Cyramza 500mg Injection avoid or limit their alcohol intake.
• Driving: Cyramza 500mg Injection may cause side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.

Side Effects:

• Serious: Blood clots, impaired wound healing, serious infusion reactions, kidney problems, hepatotoxicity (liver damage), pulmonary hemorrhage (bleeding from the lungs).
• Common: High blood pressure, fatigue, decreased appetite, nausea and vomiting, diarrhea, mouth sores, abdominal pain, headache, proteinuria (the presence of excess protein in the urine), hypothyroidism (an underactive thyroid gland), gastrointestinal bleeding, nosebleeds, bruising.

FAQs:

1. Can Cyramza 500mg Injection be used in patients with kidney disease?
   • Cyramza 500mg Injection should be used cautiously in patients with kidney disease, as it may affect kidney function. Kidney function tests should be monitored regularly during treatment, and the dosage may need to be adjusted based on the results.
2. Can Cyramza 500mg Injection cause hair loss?
   • Hair loss is not a common side effect of Cyramza 500mg Injection. However, some patients may experience hair thinning or loss due to chemotherapy or other cancer treatments combined with this medication.
3. Can Cyramza 500mg Injection cause fertility problems?
   • There is no evidence that Cyramza 500mg Injection causes fertility problems. However, it is recommended that women of childbearing age use effective contraception during treatment and for at least 3 months after the last dose, as this injection may cause harm to a developing fetus.
4. Can Cyramza 500mg Injection be used in elderly patients?
   • Yes, Cyramza 500mg Injection can be used in elderly patients. However, elderly patients may be more susceptible to certain side effects, such as bleeding or high blood pressure, and require more frequent monitoring.
5. What food should I avoid while taking Cyramza 500mg Injection?
   • There are no specific foods that need to be avoided while taking Cyramza 500mg Injection. However, following a balanced and healthy diet is important to support your overall health during treatment.

Fact Box:

• Molecule name: Ramucirumab
• Therapeutic class: Anticancer
• Pharmacological class: Monoclonal Antibody

Tags: cancer_treatment, chemotherapy, drug_injection, oncology, medication